Althea Group Holdings Limited (AGH.AX)

0.0500 0.0000 (0.00%) At close: 02:09PM AEDT

Althea Group Holdings Limited

360 Elizabeth Street
Level 50
Melbourne, VIC 3000
Australia
61 1300 70 20 20
https://altheagroupholdings.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Joshua Michael Fegan	CEO, MD & Exec. Director	685.06k	N/A	N/A
Mr. Robert Meissner	CFO & Company Sec.	403.68k	N/A	N/A
Mr. David Sauer	Gen. Counsel	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Germany, Canada, and internationally. It also offers a range of education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private medical cannabis clinic network under the MyAccess Clinics name. Althea Group Holdings Limited was founded in 2016 and is based in Melbourne, Australia.

Corporate governance

Althea Group Holdings Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.